Video
Catch up on the exciting Aesthetic Society accomplishments and advances that took place in 2023.
The Aesthetic Society Year in Review 2023/2024
Related Articles
This is my last newsletter as President of The Aesthetic Foundation, and it has been a busy and productive year. Our core mission is to support research that is relevant to practicing plastic surgeons and improve the safety and effectiveness of the procedures that we offer to our patients.
For this post hoc analysis, the authors extracted and analyzed data from the BLESS III study to determine whether there were variances in the effectiveness and safety of letibotulinumtoxinA for treating vertical glabellar lines between the broader female study population and a group of female participants aged 35 to 50.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
In this month’s update, Dr. Tracy Pfeifer highlights the importance of fellowships and residents, how AlliedPro can help evolve staff's education, The Aesthetic Cruise 2026 is almost sold out, and the upcoming Facial and Rhinoplasty Symposium!
In this update, Dr. Pfeifer talks about the upcoming program planning for Aesthetic Interactive: Facial & Rhinoplasty Symposium in Boca Raton, Florida, and The Aesthetic MEET in Boston, Massachusetts, recapping the May Master Class with Dr. Calobrace, and her upcoming trips to Monaco, New England, and Singapore!